Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 7
Submit an article Journal homepage
258
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

A mouse model of disseminated mantle cell lymphoma highlights a lack of activity of estrogen receptor β agonists toward tumor burden

Simon BodyNormandie Univ INSERM UMR1245, UNICAEN, Caen, France;
,
Anna Esteve-ArenysDivision of Hematology and Oncology, IDIBAPS, Barcelona, Spain;
,
Clara Recasens-ZorzoDivision of Hematology and Oncology, IDIBAPS, Barcelona, Spain;
,
Xavier TroussardNormandie Univ INSERM UMR1245, UNICAEN, Caen, France; ;Laboratoire d’Hématologie Biologique, CHU Côte de Nacre, Caen, France; ORCID Iconhttp://orcid.org/0000-0001-6863-9992
ORCID Icon,
Gaël RouéDivision of Hematology and Oncology, IDIBAPS, Barcelona, Spain; ;Molecular Genetics Unit, Department of Hematology, University Hospital Vall d’Hebron, Barcelona, SpainORCID Iconhttp://orcid.org/0000-0003-0245-2257
ORCID Icon &
Brigitte SolaNormandie Univ INSERM UMR1245, UNICAEN, Caen, France; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7278-9651
ORCID Icon
Pages 1726-1729 | Received 14 Aug 2017, Accepted 24 Oct 2017, Published online: 22 Nov 2017

References

  • Campo E, Rule S. Mantle cell lymphoma: evolving management strategies. Blood. 2014;125:48–55.
  • Inamdar AA, Goy A, Ayoub NM, et al. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents. Oncotarget. 2016;7:48692–48731.
  • Shain KH, Dalton WS, Tao J. The tumor microenvironment shapes hallmarks of mature B-cell malignancies. Oncogene. 2015;34:4673–4682.
  • Yakimchuk K, Jondal M, Okret S. Estrogen receptor alpha and beta in the normal immune system and in lymphoid malignancies. Mol Cell Endocrinol. 2013;375:121–129.
  • Yakimchuk K, Hasni MS, Guan J, et al. Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists. Blood. 2014;123:2054–2061.
  • Chaudhary SC, Singh T, Talwelkar SS, et al. Erb-041, an estrogen receptor beta agonist inhibits skin photocarcinogenesis in SKH-1 hairless mice by down-regulating WNT signaling pathway. Cancer Prevent Res. 2014;7:186–198.
  • Burger JA, Ford RJ. The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapies. Semin Cancer Biol. 2011;21:308–312.
  • Fidalgo M, Ben Younes K, Body S, et al. Agonists of estrogen receptor β have limited anti-myeloma activity. Blood e-Letters. [cited 2015 Sep 15]. Available from: http://www.bloodjournal.org/content/123/13/2054
  • Ladikou EE, Kassi E. The emerging role of estrogen in B cell malignancies. Leuk Lymphoma. 2017;58:528–539.
  • Moros A, Bustany S, Cahu J, et al. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes. Clin Cancer Res. 2014;20:393–403.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.